Management Team

Alzheimer’s Disease

Overview

Alzheimer’s disease accounts for one of the most prevalent causes of dementia among people aged ≥65 years (with a prevalence rate of 4.4%) and is presented more commonly in females than in males. Familial cases are observed at a younger age. Genes involved in Alzheimer’s disease include  APP, presenilin 1 and 2, and apolipoprotein E4. The initial stage of dementia is manifested as mild cognitive impairment, and presents a progression risk of 10–15% to Alzheimer’s disease.

Deposition of abnormal amyloid proteins in brain

  • Memory impairment involving recent memory and daily events
  • Challenges in acquiring and remembering new information
  • Visuospatial impairment (such as getting lost while driving)
  • Difficulty in doing learned motor activities (apraxia) like wearing clothes
  • Difficulty in finding words
  • Repetitiveness or asking the same thing repeatedly
  • Forgetfulness of past events in advanced stages
  • Behavioural changes in the form of decreased social interaction, aggressiveness, and occasionally hallucinations

  • Family history
  • Age
  • Cardiovascular diseases
  • Sedentary lifestyle
  • Head injuries
  • Loneliness and depression
  • Down’s syndrome

Neurologist

  • Clinical scores like detailed neurocognitive assessment, mini-mental state examination (MMSE), and Montreal cognitive assessment (MOCA)
  • MRI brain to evaluate loss of hippocampal volume and temporal lobe atrophy
  • FDG PET scan to check hypometabolism in these areas

  • Cognitive rehabilitation
  • Medical management through acetylcholine receptor inhibitors, N-methyl-D-aspartate receptor antagonists
  • Managing behavioural and psychiatric complications
Bottom to top